Login / Signup

Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

Fatma E El-KhoulySophie E M Veldhuijzen van ZantenVicente Santa-Maria LopezN Harry HendrikseGertjan J L KaspersG LoizosDavid SumerauerKarsten NysomKaie PruunsildVirve PentikainenHalldora K ThorarinsdottirGiedre RutkauskieneVictor CalvagnaMonika DrogosiewiczMonica DragomirLadislav DeakLidija KitanovskiAndre O von BuerenRejin KebudiIrene SlavcSandra JacobsFilip Jadrijevic-CvrljeNatacha Entz-WerleJacques GrillAntonis KattamisPeter HauserJane PearsVeronica BiassoniMaura MassiminoEnrique Lopez AguilarIngrid K TorsvikMaria Joao Gil-da-CostaElla KumirovaOfelia Cruz-MartinezStefan HolmSimon BaileyTim HaydenUlrich W ThomaleGeert O R JanssensChristof M KrammDannis G van Vuurden
Published in: Journal of neuro-oncology (2019)
This survey demonstrates a large heterogeneity of treatment regimens, especially at disease progression. We emphasize the need for international consensus guidelines for the treatment of DIPG, possible by more collaborative clinical trials.
Keyphrases
  • clinical trial
  • randomized controlled trial
  • clinical practice
  • single cell
  • cross sectional
  • phase ii
  • phase iii